130 related articles for article (PubMed ID: 38508241)
21. Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells.
Odagiri N; Matsubara T; Higuchi M; Takada S; Urushima H; Sato-Matsubara M; Teranishi Y; Yoshizato K; Kawada N; Ikeda K
Mol Cell Biochem; 2019 May; 455(1-2):7-19. PubMed ID: 30426301
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signaling.
Wu Z; Xia M; Wang J; Aguilar MM; Buist-Homan M; Moshage H
Cell Biochem Funct; 2024 Jun; 42(4):e4077. PubMed ID: 38881228
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH.
Khoury M; Guo Q; Furuta K; Correia C; Meroueh C; Kim Lee HS; Warasnhe K; Valenzuela-Pérez L; Mazar AP; Kim I; Noh YK; Holmes H; Romero MF; Sussman CR; Pavelko KD; Islam S; Bamidele AO; Hirsova P; Li H; Ibrahim SH
JHEP Rep; 2024 Jun; 6(6):101073. PubMed ID: 38882600
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.
Akdoğan Ö; Atak Yücel A; Gök Sargin Z; Sönmez C; Esendağli Yilmaz G; Özenirler S
J Clin Exp Hepatol; 2019; 9(1):29-33. PubMed ID: 30765936
[TBL] [Abstract][Full Text] [Related]
25. Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
Liu X; Xu J; Rosenthal S; Zhang LJ; McCubbin R; Meshgin N; Shang L; Koyama Y; Ma HY; Sharma S; Heinz S; Glass CK; Benner C; Brenner DA; Kisseleva T
Gastroenterology; 2020 May; 158(6):1728-1744.e14. PubMed ID: 31982409
[TBL] [Abstract][Full Text] [Related]
26. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma.
Nguyen PT; Kanno K; Pham QT; Kikuchi Y; Kakimoto M; Kobayashi T; Otani Y; Kishikawa N; Miyauchi M; Arihiro K; Ito M; Tazuma S
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3255-3268. PubMed ID: 32870388
[TBL] [Abstract][Full Text] [Related]
27. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells.
Han J; Zhang X; Lau JK; Fu K; Lau HC; Xu W; Chu ES; Lan H; Yu J
J Pathol; 2019 Aug; 248(4):488-500. PubMed ID: 30945293
[TBL] [Abstract][Full Text] [Related]
29. Antigen-driven CD8
Burtis AEC; DeNicola DMC; Ferguson ME; Santos RG; Pinilla C; Kriss MS; Orlicky DJ; Tamburini BAJ; Gillen AE; Burchill MA
bioRxiv; 2024 Mar; ():. PubMed ID: 38562766
[TBL] [Abstract][Full Text] [Related]
30. Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators.
Pastore M; Caligiuri A; Raggi C; Navari N; Piombanti B; Di Maira G; Rovida E; Piccinni MP; Lombardelli L; Logiodice F; Rombouts K; Petta S; Marra F
JHEP Rep; 2022 Apr; 4(4):100444. PubMed ID: 35252828
[TBL] [Abstract][Full Text] [Related]
31. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma.
Papadopoulos G; Giannousi E; Avdi AP; Velliou RI; Nikolakopoulou P; Chatzigeorgiou A
Front Cell Dev Biol; 2024; 12():1343806. PubMed ID: 38774646
[TBL] [Abstract][Full Text] [Related]
32. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
33. Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models.
Dai H; Zhu C; Huai Q; Xu W; Zhu J; Zhang X; Zhang X; Sun B; Xu H; Zheng M; Li X; Wang H
J Hepatol; 2024 Jun; 80(6):913-927. PubMed ID: 38340812
[TBL] [Abstract][Full Text] [Related]
34. Hepatic stellate cell interferes with NK cell regulation of fibrogenesis via curcumin induced senescence of hepatic stellate cell.
Jin H; Jia Y; Yao Z; Huang J; Hao M; Yao S; Lian N; Zhang F; Zhang C; Chen X; Bian M; Shao J; Wu L; Chen A; Zheng S
Cell Signal; 2017 May; 33():79-85. PubMed ID: 28188823
[TBL] [Abstract][Full Text] [Related]
35. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA
Xie Y; Huang Y; Li ZY; Jiang W; Shi NX; Lu Y; Cao G; Yin Z; Lin XJ
Mol Cancer; 2024 May; 23(1):95. PubMed ID: 38720319
[TBL] [Abstract][Full Text] [Related]
37. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
[TBL] [Abstract][Full Text] [Related]
38. Senolytic CAR T cells reverse senescence-associated pathologies.
Amor C; Feucht J; Leibold J; Ho YJ; Zhu C; Alonso-Curbelo D; Mansilla-Soto J; Boyer JA; Li X; Giavridis T; Kulick A; Houlihan S; Peerschke E; Friedman SL; Ponomarev V; Piersigilli A; Sadelain M; Lowe SW
Nature; 2020 Jul; 583(7814):127-132. PubMed ID: 32555459
[TBL] [Abstract][Full Text] [Related]
39. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
40. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis.
Wang S; Li K; Pickholz E; Dobie R; Matchett KP; Henderson NC; Carrico C; Driver I; Borch Jensen M; Chen L; Petitjean M; Bhattacharya D; Fiel MI; Liu X; Kisseleva T; Alon U; Adler M; Medzhitov R; Friedman SL
Sci Transl Med; 2023 Jan; 15(677):eadd3949. PubMed ID: 36599008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
